Xavier Darcos appointed President of the Sanofi Espoir Foundation
Paris, France - November 18, 2015 - Sanofi (http://www.sanofi.com) announced today the appointment of Xavier Darcos as President of the Sanofi Espoir Foundation. Xavier Darcos succeeds Jean-François Dehecq, whose term in office has come to a close.
"I wish to thank Jean-François Dehecq for his involvement in the Sanofi Espoir Foundation. Under his Presidency, the Foundation acquired a status which has placed it amongst the best, notably for its activities in the developing countries," said Olivier Brandicourt, M.D., Chief Executive Officer, Sanofi. "I am convinced that Xavier Darcos will continue with the work already accomplished. The task remains huge, since the needs for prevention and for access to care and information are significant in the field of global health."
The mission of the Sanofi Espoir Foundation is to contribute to reducing inequalities in health and poverty, which put a strain on the development of many countries. At the end of 2014, the Foundation coordinated 58 development aid programs in 41 countries, focusing on three major fields:
- Reducing childhood cancer in countries with low to moderate resources.
- Reducing maternal and neonatal mortality, in Africa, Asia and Latin America.
- Improving access to healthcare for the most defenseless communities, in France and abroad, through healthcare pilot programs.
"Presiding over the Sanofi Espoir Foundation is a great honor for me," declared Xavier Darcos. "I shall use my experience as ambassador to promote the Foundation's actions in terms of international solidarity. The nobleness of these commitments in favor of access to healthcare for the most defenseless populations and the results obtained make the Foundation all the more remarkable."
Biography of Xavier Darcos
The French academic, civil servant and politician Xavier Darcos has been Senator and Mayor of Périgueux, Minister of School Education from 2002 to 2004, then Minister of Development, Cooperation and Francophony from 2004 to 2005, Minister of National Education from 2007 to 2009, and then Minister of Labor, Social Affairs, Family, Solidarity and Cities from 2009 to 2010.
Xavier Darcos has also been an ambassador, representing France with the OECD from 2005 to 2007, then ambassador for France's foreign cultural policy and, in this capacity, Executive President of the French Institute from June 2010 to January 2015. Since February 2015, he has been ambassador for French people living abroad.
As a man of the arts and a scholar, Xavier Darcos has been, since October 2010, Permanent Secretary of the Académie des sciences morales et politiques [Academy of Moral and Political Sciences] to which he was elected in 2006. Since June 2013, he has been a member of the Académie française [French Academy].
About the Sanofi Espoir Foundation
The Sanofi Espoir Foundation was created in 2010 by Sanofi to leverage more than 20 years of commitment to international solidarity and to make this commitment more tangible for the interested parties, within the scope of its social responsibility strategy. For more information, visit www.fondation-sanofi-espoir.com (http://www.fondation-sanofi-espoir.com)
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN (http://en.sanofi.com/investors/share/stock_chart/stock_chart.aspx)) and in New York (NYSE: SNY (http://en.sanofi.com/investors/share/stock_chart/stock_chart.aspx)).
Contacts:
| Sanofi Media Relations Laurence Bollack Tel.: +33 (0)1 53 77 46 46 mr@sanofi.com (mailto:mr@sanofi.com) | Sanofi Investor Relations Sébastien Martel Tel.: + 33 (0) 1 53 77 45 45 ir@sanofi.com (mailto:ir@sanofi.com) |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via Globenewswire
